Cutaneous T-cell lymphomas may require an exception to the ABHH consensus regarding empiric vancomycin use in febrile neutropenia
- PMID: 40382880
- PMCID: PMC12145817
- DOI: 10.1016/j.htct.2025.103844
Cutaneous T-cell lymphomas may require an exception to the ABHH consensus regarding empiric vancomycin use in febrile neutropenia
Conflict of interest statement
Conflicts of interest Yung Gonzaga received honoraria and speakers' fees from Takeda. Jose A. Sanches received honoraria and speakers' fees from Takeda.
Similar articles
-
Pre-emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer.Cochrane Database Syst Rev. 2022 Nov 28;11(11):CD013604. doi: 10.1002/14651858.CD013604.pub2. Cochrane Database Syst Rev. 2022. PMID: 36440894 Free PMC article.
-
Management of febrile neutropenia: consensus of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy - ABHH.Hematol Transfus Cell Ther. 2024 Dec;46 Suppl 6(Suppl 6):S346-S361. doi: 10.1016/j.htct.2024.11.119. Epub 2024 Dec 18. Hematol Transfus Cell Ther. 2024. PMID: 39694764 Free PMC article.
-
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.Eur J Cancer. 2006 Oct;42(15):2433-53. doi: 10.1016/j.ejca.2006.05.002. Epub 2006 Jun 5. Eur J Cancer. 2006. PMID: 16750358
-
Colony stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia.Cochrane Database Syst Rev. 2005 Jul 20;(3):CD004139. doi: 10.1002/14651858.CD004139.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034921
-
Reducing inappropriate antibiotic use in febrile neutropenia in hematology patients through the implementation of an antibiotic de-escalation protocol.Infect Control Hosp Epidemiol. 2025 May 16;46(7):1-6. doi: 10.1017/ice.2025.90. Online ahead of print. Infect Control Hosp Epidemiol. 2025. PMID: 40375804 Free PMC article.
References
-
- Nucci M., Arrais-Rodrigues C., Bergamasco M.D., Garnica M., Gloria A.B.F., Guarana M., et al. Management of febrile neutropenia: consensus of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy - ABHH. Hematol Transfus Cell Ther. 2024;46(Suppl 6):S346–S361. doi: 10.1016/j.htct.2024.11.119. - DOI - PMC - PubMed
-
- Martinez-Nadal G., Puerta-Alcalde P., Gudiol C., Cardozo C., Albasanz-Puig A., Marco F., et al. Inappropriate empirical antibiotic treatment in high-risk neutropenic patients with bacteremia in the era of multidrug resistance. Clin Infect Dis. 2020;70(6):1068–1074. doi: 10.1093/cid/ciz319. - DOI - PubMed
-
- Chumbita M., Puerta-Alcalde P., Gudiol C., Garcia-Pouton N., Laporte-Amargós J., Ladino A., et al. Impact of empirical antibiotic regimens on mortality in neutropenic patients with bloodstream infection presenting with septic shock. Antimicrob Agents Chemother. 2022;66(2) doi: 10.1128/AAC.01744-21. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources